Comparison of survival between diabetic and non-diabetic patients on maintenance hemodialysis: A single-centre experience

Diabetes Research and Clinical Practice

Volumn 75, Issue 2, 2007, Pages 169-175

  Rački, Sanjin ^a   Zaputović, Luka ^a   Vujičić, Božidar ^b   Crnčević Orlić, Željka ^a   Dvornik, Štefica ^a   Mavrić, Žarko ^a  

^a KBC RIJEKA   (Croatia)

^b Health Centre Umag   (Croatia)

Author keywords

Cardiovascular diseases; Diabetic nephropathy; Hemodialysis; Risk factors; Survival

Indexed keywords

CELLULOSE ACETATE; ERYTHROPOIETIN; POLYSULFONE;

ACUTE HEART INFARCTION; ADULT; AGED; ANEMIA; ARTICLE; ARTIFICIAL KIDNEY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CROATIA; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EARLY DIAGNOSIS; EVALUATION; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; INFECTION COMPLICATION; INTERSTITIAL NEPHRITIS; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; KIDNEY FAILURE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PYELONEPHRITIS; RISK FACTOR; SEPSIS; SURVIVAL RATE; VASCULAR DISEASE;

ADULT; AGED; CROATIA; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PATIENT SELECTION; RENAL DIALYSIS; SURVIVAL ANALYSIS;

EID: 33845483370     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.05.015     Document Type: Article

References (30)

1. Diabetes Statistics. American Diabetes Association. Available at: http://www.diabetes.org/diabetes-statistics.jsp. Accessed April 28, 2006.
2. Diabesity is a registered trademark of Shape Up America! Available at: http://www.shapeup.org/prof/diabesity.php. Accessed April 28, 2006.
3. Harvey J.N. Trends in the prevalence of diabetic nephropathy in type 1 and type 2 diabetes. Curr. Opin. Nephrol. Hypertens. 12 (2003) 317-322
4. Croatian registry for renal replacement therapy 2003, Croatian Society for Nephrology, Dialysis and Transplantation, Available from: http://www.hdndt.org/registar_crrt03.htm. Accessed: May 1, 2005.
5. Polenakovic M.H. Options in uraemia therapy for diabetics with end-stage renal disease. Prilozi 25 (2004) 27-51
6. Giri M. Choice of renal replacement therapy in patients with diabetic end stage renal disease. EDTNA ERCA J. 30 (2004) 138-142
7. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, US Renal Data System, USRDS 2004 Annual Data Report, Am. J. Kidney Dis. 45(Suppl. 1) (2005) S8-270.
8. Batista P.B., Lopes A.A., and Costa F.A. Association between attributed cause of end-stage renal disease and risk of death in Brazilian patients receiving renal replacement therapy. Ren. Fail. 27 (2005) 651-656
9. Hocher B., Ziebig R., Altermann C., Krause R., Asmus G., Richter C.M., et al. Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis. J. Am. Soc. Nephrol. 14 (2003) 2329-2337
10. European best practice gudelines for hemodialysis; section II: Hemodialysis adequacy, Nephrol. Dial. Transplant 17 (2002) 17-21.
11. Racki S., Zaputovic L., Maleta I., Grzetic M., Mavric Z., Devcic B., et al. Assessment of hemodialysis adequacy by ionic dialysance: comparison to standard method of urea removal. Ren. Fail. 27 (2005) 601-604
12. Anderson K.M., Castelli W.P., and Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 257 16 (1987) 2176-2180
13. Kanell W.B., and McGee D.L. Diabetes and cardiovascular risk factors: the Framingham Study. Circulation 59 1 (1979) 8-13
14. Kanell W.B. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 275 20 (1996) 1571-1576
15. G. De Backer on behalf of Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice, European guidelines on cardiovascular disease prevention in clinical practice, Euro. Heart J. 24 (2003) 1601-1610.
16. Sokolow M., and Lyon T.P. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am. Heart. J. 37 (1949) 161-186
17. McCullough P.A. Interface between renal disease and cardiovascular illness. In: Zipes D.P., Libby P., Bonow R.O., and Braunwald E. (Eds). Braunwald's Heart Disease (2005), Elsevier Saunders, Philadelphia, PA 2161-2172
18. Ghavamian M., Gutch C.F., Kopp K.F., and Kolff W.J. The sad truth about hemodialysis in diabetic nephropathy. J. Am. Med. Assoc. 222 (1972) 1386-1389
19. Ritz E., Rychlik I., Locatelli F., and Halimi S. End-stage renal failure in type 2 diabetes: a medical catastrophe of world wide dimensions. Am. J. Kidney Dis. 34 (1999) 795-808
20. Koch M., Kutkuhn B., Grabensee B., and Ritz E. Apolipoprotein A, fibrinogen, age, and history of stroke are predictors of death in dialysed diabetic patients: a prospective study in 412 subjects. Nephrol. Dial. Transplant 12 (1997) 2603-2611
21. Wu M.S., Yu C.C., Yang C.W., Wu C.H., Haung J.Y., Hong J.J., et al. Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance hemodialysis. Nephrol. Dial. Transplant 12 (1997) 2105-2110
22. Cheung A.K., Sarnak M.J., Yan G., Berkoben M., Heyka R., Kaufman A., et al. HEMO Study group, cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int. 65 (2004) 2380-2389
23. Held P.J., Port F.K., Wolfe R.A., Stannard D.C., Carroll C.E., Daugirdas J.T., et al. The dose of hemodialysis and patient mortality. Kidney Int. 50 (1996) 550-556
24. Pupim L.B., Caglar K., Hakim R.M., Shyr Y., and Alp Ikizler T. Uremic malnutrition is a predictor of death independent of inflammatory status. Kidney Int. 66 (2004) 2054-2060
25. Stenvinkel P., Heimbürger O., Paultre F., Diczfalusy U., Wang T., Berglund L., et al. Strong association between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int. 55 (1999) 1899-1911
26. Kalantar-Zadeh K., Block G., Humphreys M.H., and Kopple J.D. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 63 (2003) 793-808
27. Tschöpe W., Koch M., Thomas B., Ritz E., and The German Study Group Diabetes and Uremia. Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis. Results of a prospective study. Nephron 64 (1993) 354-358
28. Foley R.N., Culleton B.F., Parfrey P.S., Harnett J.D., Kent G.M., Murray D.C., et al. Cardiac disease in diabetic end-stage renal disease. Diabetologia 40 (1997) 1307-1312
29. Adler A.I., Stevens R.J., Manley S.E., Bilous R.W., Cull C.A., Holman R.R., and UKPDS Group. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 63 (2003) 225-232
30. Parving H.H., Lewis J.B., Ravid M., Remuzzi G., and Hunsicker L.G. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 69 (2006) 2057-2063